Latest Articles and Analysis

HIV-MPV co-infection rates between 28-51% indicate need for targeted interventions and provider education.

Place-based sexual health care in community venues advances HIV/HCV prevention and testing outreach.

Nevada expands syringe vending machines with naloxone, fentanyl strips; anonymity critical for uptake.

Employers can advance health equity through inclusive benefits design and quality provider networks.

US Trans Survey provides critical data on transgender healthcare, discrimination, and social determinants.

State-level MPV surveillance: Black Americans overrepresented in Southern states amid reporting gaps.

2022-2023 respiratory season tracking flu, COVID-19, and RSV with severe early indicators.

Q4 2022 Watch: HHS renewed opioid emergency; CANN launched monkeypox project; HEPLISAV-B hepatitis B vaccine covered.

Louisiana and Washington HCV subscription models save millions but fail elimination goals; cost alone isn't the barrier.

Monitoring report documents HCV treatment access challenges across ADAP, Medicaid, and VA systems.

Patients face multiple monkeypox barriers: disorganized state websites, limited vaccine access, reporting gaps.

ADAP Fireside Chat addresses counterfeit medications, 340B reform, and public health workforce sustainability.

S.4395 would divert Ryan White resources from PLWHA to PrEP, threatening the safety net for vulnerable populations.

Provider language shows negative bias toward Black patients at 2.5x rate, undermining care engagement.

Overdose Awareness Day calls for holistic interventions addressing SUD as a health issue, not criminal one.

White House releases federal implementation plan with 380+ action items for National HIV/AIDS Strategy.

European Commission approves lenacapavir, a novel six-month injectable for treatment-resistant HIV.

Stigma drives opposition to harm reduction programs like safe consumption sites despite strong evidence.

Only 35% of privately insured and 23% of Medicaid patients initiate HCV treatment due to payer barriers.

US monkeypox response: 31% of cases among Black persons, vaccine distribution equity concerns persist.